Contemporary Management of Complex Skin Cancers

1. Improve the understanding of contemporary treatment of myeloproliferative neoplasms (MPNs)

2. Recognize the key molecular drivers of MPNs as well as appropriate testing for response and resistance to therapy

3. Gain insight into novel experimental therapy options for MPNs